• Member Statistics

    • 791,209 Colleagues-to-Date [Sponsored by a generous R&D grant from iMBA, Inc.]
  • David E. Marcinko [Editor-in-Chief]

    As a former Dean and appointed Distinguished University Professor and Endowed Department Chair, Dr. David Edward Marcinko MBA was a NYSE broker and investment banker for a decade who was respected for his unique perspectives, balanced contrarian thinking and measured judgment to influence key decision makers in strategic education, health economics, finance, investing and public policy management.

    Dr. Marcinko is originally from Loyola University MD, Temple University in Philadelphia and the Milton S. Hershey Medical Center in PA; as well as Oglethorpe University and Emory University in Georgia, the Atlanta Hospital & Medical Center; Kellogg-Keller Graduate School of Business and Management in Chicago, and the Aachen City University Hospital, Koln-Germany. He became one of the most innovative global thought leaders in medical business entrepreneurship today by leveraging and adding value with strategies to grow revenues and EBITDA while reducing non-essential expenditures and improving dated operational in-efficiencies.

    Professor David Marcinko was a board certified surgical fellow, hospital medical staff President, public and population health advocate, and Chief Executive & Education Officer with more than 425 published papers; 5,150 op-ed pieces and over 135+ domestic / international presentations to his credit; including the top ten [10] biggest drug, DME and pharmaceutical companies and financial services firms in the nation. He is also a best-selling Amazon author with 30 published academic text books in four languages [National Institute of Health, Library of Congress and Library of Medicine].

    Dr. David E. Marcinko is past Editor-in-Chief of the prestigious “Journal of Health Care Finance”, and a former Certified Financial Planner® who was named “Health Economist of the Year” in 2010. He is a Federal and State court approved expert witness featured in hundreds of peer reviewed medical, business, economics trade journals and publications [AMA, ADA, APMA, AAOS, Physicians Practice, Investment Advisor, Physician’s Money Digest and MD News] etc.

    Later, Dr. Marcinko was a vital recruited BOD member of several innovative companies like Physicians Nexus, First Global Financial Advisors and the Physician Services Group Inc; as well as mentor and coach for Deloitte-Touche and other start-up firms in Silicon Valley, CA.

    As a state licensed life, P&C and health insurance agent; and dual SEC registered investment advisor and representative, Marcinko was Founding Dean of the fiduciary and niche focused CERTIFIED MEDICAL PLANNER® chartered professional designation education program; as well as Chief Editor of the three print format HEALTH DICTIONARY SERIES® and online Wiki Project.

    Dr. David E. Marcinko’s professional memberships included: ASHE, AHIMA, ACHE, ACME, ACPE, MGMA, FMMA, FPA and HIMSS. He was a MSFT Beta tester, Google Scholar, “H” Index favorite and one of LinkedIn’s “Top Cited Voices”.

    Marcinko is “ex-officio” and R&D Scholar-on-Sabbatical for iMBA, Inc. who was recently appointed to the MedBlob® [military encrypted medical data warehouse and health information exchange] Advisory Board.

    entrepreneur

    Frontal_lobe_animation

  • ME-P Information & Content Channels

  • ME-P Archives Silo [2006 – 2020]

  • Ann Miller RN MHA [Managing Editor]

    ME-P SYNDICATIONS:
    WSJ.com,
    CNN.com,
    Forbes.com,
    WashingtonPost.com,
    BusinessWeek.com,
    USNews.com, Reuters.com,
    TimeWarnerCable.com,
    e-How.com,
    News Alloy.com,
    and Congress.org

    Comprehensive Financial Planning Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners(TM)

    Product Details

    Product Details

    Product Details

  • CERTIFIED MEDICAL PLANNER® program

    New "Self-Directed" Study Option SinceJanuary 1st, 2018
  • Most Recent ME-Ps

  • PodiatryPrep.org


    BOARD CERTIFICATION EXAM STUDY GUIDES
    Lower Extremity Trauma
    [Click on Image to Enlarge]

  • ME-P Free Advertising Consultation

    The “Medical Executive-Post” is about connecting doctors, health care executives and modern consulting advisors. It’s about free-enterprise, business, practice, policy, personal financial planning and wealth building capitalism. We have an attitude that’s independent, outspoken, intelligent and so Next-Gen; often edgy, usually controversial. And, our consultants “got fly”, just like U. Read it! Write it! Post it! “Medical Executive-Post”. Call or email us for your FREE advertising and sales consultation TODAY [770.448.0769]

    Product Details

    Product Details

  • Medical & Surgical e-Consent Forms

    ePodiatryConsentForms.com
  • iMBA R&D Services

    Commission a Subject Matter Expert Report [$250-$999]January 1st, 2019
    Medical Clinic Valuations * Endowment Fund Management * Health Capital Formation * Investment Policy Statement Analysis * Provider Contracting & Negotiations * Marketplace Competition * Revenue Cycle Enhancements; and more! HEALTHCARE FINANCIAL INDUSTRIAL COMPLEX
  • iMBA Inc., OFFICES

    Suite #5901 Wilbanks Drive, Norcross, Georgia, 30092 USA [1.770.448.0769]. Our location is real and we are now virtually enabled to assist new long distance clients and out-of-town colleagues.

  • ME-P Publishing

  • SEEKING INDUSTRY INFO PARTNERS?

    If you want the opportunity to work with leading health care industry insiders, innovators and watchers, the “ME-P” may be right for you? We are unbiased and operate at the nexus of theoretical and applied R&D. Collaborate with us and you’ll put your brand in front of a smart & tightly focused demographic; one at the forefront of our emerging healthcare free marketplace of informed and professional “movers and shakers.” Our Ad Rate Card is available upon request [770-448-0769].

  • Reader Comments, Quips, Opinions, News & Updates

  • Start-Up Advice for Businesses, DRs and Entrepreneurs

    ImageProxy “Providing Management, Financial and Business Solutions for Modernity”
  • Up-Trending ME-Ps

  • Capitalism and Free Enterprise Advocacy

    Whether you’re a mature CXO, physician or start-up entrepreneur in need of management, financial, HR or business planning information on free markets and competition, the "Medical Executive-Post” is the online place to meet for Capitalism 2.0 collaboration. Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds. ******************************************************************** THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
  • OIG Fraud Warnings

    Beware of health insurance marketplace scams OIG's Most Wanted Fugitives at oig.hhs.gov

On Microsoft Health Accelerator, Merck Accelerator and Samsung NEXT

Microsoft Accelerator, Merck Accelerator and Samsung NEXT
have the highest awareness of all corporate health accelerators

By Markus Pohl

Among corporate health accelerators Microsoft Accelerator has the highest awareness level. Merck Accelerator and Samsung NEXT are ranking second and third. 42.8% of the digital health community has heard of Microsoft Accelerator. 26.7% have heard of Merck Accelerator, 26.4% of SAMSUNG Next and 24.8% of Grants4Apps by Bayer. Techstars (Barclays Accelerator, London) (18.2%) follows fifth with some distance behind.

These findings are part of our mHealth Economics program, the biggest survey of its kind with 2,400 answers from the digital global health community. In the ranking of of corporate accelerators’ awareness 21 corporate accelerators investing in healthcare have been included.

***

Here is the full ranking:

https://research2guidance.com/microsoft-accelerator-merck-accelerator-and-samsung-next-have-the-highest-awareness-of-all-corporate-health-accelerators/

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements.

Book Marcinko: https://medicalexecutivepost.com/dr-david-marcinkos-bookings/
Subscribe: MEDICAL EXECUTIVE POST for curated news, essays, opinions and analysis from the public health, economics, finance, marketing, IT, business and policy management ecosystem.

***

Healthcare Technology in the News

Join Our Mailing List

By Staff Reporters

Healthcare consumers show mounting interest in virtual, on-demand care
Fierce Healthcare, August 14, 2017

Transforming the mHealth Experience With Digital Health Assistants
HIT Consultant, August 14, 2017

Google buys smartphone health monitoring startup Senosis
Pharma Phorum, August 14, 2017

Could Trump’s Opioid Emergency Boost Telemedicine, mHealth Use?
mHealth Intelligence, August 11, 2017

Trump Administration Takes on VA Telehealth Opportunities
The Natonal Law Review, August 11, 2017

More and more businesses are offering telehealth services as an employee benefit
MedCity News, August 9, 2017

VR Glasses Give Doctors a New mHealth Tool to Treat Concussions
mHealth Intelligence, July 31, 2017

New Senate bill seeks to reduce restrictions on telemedicine use
MobiHealth News, July 31, 2017

The allure of health care for tech giants
Axios, July 20, 2017

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

Product DetailsProduct Details

***

Chance of leading Pharma companies producing a successful app has decreased from 2.0% (2014) to 0.5% (2016)

Pharma Report Findings

By David Ireland Berlin

[Research2Guidance ]

Leading Pharma companies continue to struggle to gain significant reach (downloads) within their target groups. While companies have cumulatively over doubled their number of active apps available on Apple App and Google Play stores (2014 – Q1 2017), most have added to the growing tail of under performers.

Why is it that Pharma companies continue to struggle in mhealth?

Have they showed other signs of improvement within their app portfolios, or through 3rd party digital eco-systems?

Only 0.5% of all apps published by the leading 12 Pharma companies have managed to achieve annual downloads of over 100K; one of the major findings from the recently published, 2nd edition Pharma App Benchmarking 2017 report by Research2Guidance.

The report builds on figures identified from the previous edition, released in 2014. It also explores the leading 3rd party digital innovation strategies, their components, and their successfulness in terms of benefits (ROI, reach etc.). While companies have on average increased their app portfolio sizes from 65 to 153, average per app annual downloads remain low at just 3.3K.

Here are three of the main reasons why:

1. Companies are competing against a growing number of mhealth competitors. According to the 2016 mhealth Developer Economics Report, there were 290K mhealth apps listed on major app stores, an increase of +174K since 2014. Annual mhealth app download growth rates are also decreasing, adding to the growing pressure.

2. Pharma app portfolios have a narrower target audience than their mhealth competitors. App portfolios of Pharma companies differ from the average mhealth app portfolio in the greater degree to which they supply apps for HCP use cases. When comparing the app categorization differences between Pharma and mhealth, Pharma tends to target a greater share of patients over healthy individuals. This in turn decreases their potential target audience, making it harder to generate downloads.

3. Apps, on average, still fall behind their mhealth competitors in terms of product quality. Pharma app portfolios are not achieving the reach and retention experienced by the average mhealth provider. Inconsistencies of design elements and cross-referencing between apps are still far too common, and continue to let Pharma app quality down.

With the hype of, for example, Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR), connected devices and sensors mounting throughout the digital health industry, consumers are simply demanding more usability from their mhealth products and services.

Life-Cycles

Traditional Pharma product production life-cycles are simply incompatible when dealing with their digital offerings, given the rate of technological change. However, there are a few instances whereby Pharma companies have achieved some success with their internal app publishing.

Johnson&Johnson for example have published three of the five most downloaded Pharma apps for 2016; J&J Official 7 Minute Workout and onetouch Reveal. All three achieved over 200K downloads for 2016. The success of their leading apps has improved their portfolios overall performance in comparison to 2014.

***
***
 

All leading Pharma companies have grown their internal app portfolio size since 2014, and all but two (Abbott and Sanofi) have increased their reach.

However, thanks to the growing app portfolio size of Bayer and Novartis, and the high downloads of J&J, half of the leading Pharma companies have portfolios that fall below the average-lines. Previously, this was the case for five companies.

Taking J&J as an example, the success of a mere two or three apps can result in Pharma app market leadership.

Take Sanofi as another example. With the hype of Sanofi’s previous most downloaded app coming to an end (GoMeals), their internal app portfolio has experienced a significant decrease in annual downloads in comparison to 2014. Their portfolio has now fallen to 4th place in terms of reach behind J&J, Bayer and GSK. Novartis, Sanofi and Bayer have made the most significant strides in their app publishing activities, but are not seeing the ROI in the way of market penetration.

The newly released Pharma report goes into more company level detail on supply and demand from a platform, category, use-case and user-retention perspective. The report also analyses the 3rd party digital eco-system activities and strategies of these companies. Some appear to be relying more heavily on their 3rd party channels to source digital innovation than others, and their achievements to date give insight into which channels create the most potential for overall benefit to the Pharma company. These benefits can range from, for example, brand image improvement, digital innovation adoption, and new product distribution channels.

Assessment

Find out more about the app portfolios and digital strategies of leading Pharma companies by downloading your copy of the report today. Click here to find out more about what’s inside.                                                                                                          

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

Product DetailsProduct Details

***

The mHealth app Market is getting CROWDED

Join Our Mailing List 

There are 259,000 mHealth apps now

ralfBy Ralf-Gordon Jahns

ralf.jahns@research2guidance.com

Almost 100,000 mHealth apps have been added since the beginning of last year, amounting to 259,000 currently available on major app stores. In addition, 13,000 mHealth publishers have entered the market since the beginning of 2015, totaling 58,000. The largest global study on mHealth app publishing reveals a massive increase in competition in the mHealth app market.

The results of this year’s mHealth App Developer Economics 2016 study show a steep increase in competition level among mHealth app publishers. The supply side of mHealth apps is measured in the number of available apps and publishers. They are growing significantly faster than the demand side which is quantified by the number of mHealth app downloads. The number of mHealth apps and active mHealth app publishers has seen strong growth since 2015. This year, the total number of mHealth apps listed on major app stores across the globe grew by 57% to 259,000 apps.

“This impressive growth is based on three main developments; the growing number of mHealth app publishers, the increased importance of multi-platform app publishing and the expansion of existing mHealth app portfolios”

The number of mHealth app publishers grew in line with the number of apps. There are currently 58,000 mHealth app publishers app on major app stores, 28% more since the beginning of 2015. There appears to be no immediate end to the number of companies rushing into the market to launch their first mHealth app. Multi-platform publishing also contributes to the growth on the supply side of the mHealth app market.

***

it-is-getting-crowded

***

Currently 75% of mHealth publishers are developing their mHealth apps both on iOS and Android platforms. Multi-platform publishing is even more significant for HTML5 and Windows Phone developers, however these platforms are still niche and don’t contribute a lot to the overall number of mHealth apps yet.

In contrast, growth rates of mHealth app store downloads are estimated to be only +7% in 2016, having been +35% the previous year, reaching a total of 3.2B in 2016. This is in line with other app market categories and reflects the fact that growth of capable devices that can download apps has slowed down in most western countries. As a consequence of this increased competition, it will be even more difficult to stand out and gain significant downloads. Only 14% of mHealth app publishers generated more than 100,000 downloads with their mHealth app portfolio in one year. This share increased only marginally by 3pp since 2014.

“Consumers are still downloading mHealth apps because they have heard about them or found them in the app store” explains Audrone Skardziute, Analyst at research2guidance. “The next push on the demand side will come from recommendations of traditional healthcare companies that are pushing apps to their employees or members.”

With hundreds of new mHealth apps released daily, companies have to consider their app launch as if it were a familiar product in a saturated market. The mHealth Developer Economics 2016 research program is the largest research program about mHealth app publishing. This year more than 2,600 mHealth app developers and decision makers participated and shared their experiences and views about the mHealth app market. There is much more and we will continue to write about the results of the study. Read the full report to see all results.

MORE: Download the free 28 page report here.

About

research2guidance is a Berlin-based mobile app economy specialist. The company’s service offerings include app strategy consulting, market studies and research.

Link to the report:

http://research2guidance.com/product/mhealth-app-developer-economics-2016/

Link to the blog post: http://research2guidance.com/2016/10/11/mhealth-app-market-getting-crowded-259000-mhealth-apps-now/ Link to the image: http://research2guidance.com/wp-content/uploads/2016/10/It-is-getting-crowded.png

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

Product DetailsProduct Details

***

Using mHealth to facilitate end-of-life care

Join Our Mailing List

An Infographic

Last week was National Healthcare Decisions Day (NHDD), “a day devoted to encouraging the completion of advance directives.”

When discussing end-of-life care, it’s a delicate issue that has to be handled carefully – and one in which mHealth can play an important role.

SOAR

***

“There are serious communication challenges around advance care planning and they contribute to the emotional and financial burdens on patients, their families and their caretakers,” Geri Lynn Baumblatt, executive director of patient engagement for Emmi Solutions, said in a press release.

“Empowering people to make decisions about their own care before reaching a point where they can no longer speak for themselves can shift that experience from one of stress and confusion to one where everyone involved including the family and care team is readily prepared to follow the person’s wishes.”

“In a study of ICU patients with terminal conditions, only 12 percent of patients with an advance directive had received input from their physician in its development while another study showed that between 65 and 76 percent of physicians whose patients had an advance directive were not aware that it existed,” Nathan Kottkamp, founder of NHDD, in the release.

“These findings show that there is a huge communication gap between patients and their doctors around end of life care, NHDD’s mission is to help close that gap while Emmi Solutions’ program is a useful tool for doing so.”

For a closer look at how mHealth figures into advance directives, take a look at this infographic from Emmi Solutions.

***

end

[Click image to enlarge]

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

Product DetailsProduct Details

The Medical Industry is Going Mobile?

Join Our Mailing List

m-Health is Taking Off!

By Apollo Matrix

mobile

More: Comprehensive Financial Planning Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners™

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

Product DetailsProduct Details

 

Six groups that will shape mHealth apps of the future

Join Our Mailing List 

A Special ME-P Report

The Distinct Segment Publishers

By Ralf-Gordon Jahns and Markus Pohl

ralphmarkus

 

 

 

 

 

Introduction

Dr. Marcinko and ME-P Readers and Subscribers,

Did you know that mHealth app publishers can be grouped into 6 distinct segments?

Segments differ mainly by goals, business approaches and performance. Their desire to help others distinguishes them from the rest of the app community. Knowing these segments is a pre-requisite for all those who wish to successfully participate in the new mHealth app ecosystem.

The Publishers

So, who is behind the 100,000 mHealth apps published in today’s app stores? How do the publishers differ in terms of motivation, development tool usage and satisfaction about goals achieved? The mHealth app publisher segmentation distinguishes 6 groups of current mHealth app publishers. This segmentation is based on the results of themHealth App Developer Economics 2014study.

A deeper knowledge about the mHealth app publishers is essential to all health market participants who wish to successfully navigate inside the newly emerging mHealth app ecosystem.

mHealth app publishers are not like game or tool app developers. 46% publish apps, because they want to help others. They also have objectives like revenue generation or raising brand awareness, but this “altruistic” attitude clearly distinguishes them from the rest of the app economy.

Within the six mHealth app companies, publishers with a strong medical background and those who leverage existing app development tools & APIs seem to accomplish their goals better than those who do that to a lesser extent.

Traditional healthcare players like Pharma, Med-tech or insurance companies have not been able to define their role in the market yet. Established Healthcare Players are the only segment “mainly not” satisfied with their goal achievement.

These are the profiles of the 6 distinct mHealth app publisher segments:

1) Established healthcare players:

This group includes Pharma, hospitals, health insurance and Med-tech companies, representing 3.4% of the total number of app publishers. These players usually belong to the mHealth app publishers with > 5,000 employees. Their primary objective for being in the market is to raise brand awareness and they have published the largest number of mHealth apps. Nevertheless, average reach in terms of downloads is far below the market’s average. App publishers in this group are so far the least satisfied with the achievements in the mHealth app market. The usage of tools and APIs to improve the efficiency of the app development process and app monitoring as well as the value of the app is below its competitors.

2) App specialists:

App specialists are small companies, which typically hire 3-10 employees. They have entered the mHealth app market in order to benefit from its potential. They have an app developer background and are familiar with available development and support tools. The share of medical experts on board is relatively low. This group constitutes 14% of the mHealth app publisher community.

3) Helpers:

Helpers’ primary motivation for publishing apps is to help others and they are usually organized into small companies of 3-10 employees. Revenue generation is only a minor factor. Typically Helpers have already achieved or over-achieved their goals. In terms of downloads, they have the highest share of companies (61%) that achieved less than 5,000 downloads last year. Helpers represent 32% of the market.

4) Medical specialists:

Medical specialists leverage their medical know-how to develop mobile apps. Similar to the Helper group, Medical specialist have a large share of members who publish apps to help others. By far they have partly reached their goals. They have the highest share of companies, which in 2013 earned more than USD 1m with their mHealth app portfolio. They represent 20% of the market.

5) Fitness specialists:

This group of app developers represents around 10% of the total mHealth app developer community. They primarily develop fitness apps with a clear objective to generate revenue. They connect more often to medical databases and sensors and use app development tools above average. The usual company size is 11-100 employees.

6) Connecters:

This group of mHealth app publishers represents 18% of the total mHealth app developer community. Their strategy is to create value rich apps by enabling connection to other apps, sensors and databases. This group generates the highest average revenue and has the highest goal achievement level.

Apps

Assessment 

The mHealth app publisher segmentation is a snapshot of the current state of the market. It will change as segments become more important (medical specialists) or new groups appear.  One of the main questions will be if and how traditional healthcare players will be able to compete with these small and agile companies that are driving the market today.

More:

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos

References:

Link to blog post:

http://mhealtheconomics.com/mhealth-segmentation-of-app-publishers-business-approaches/

Link to graph:

http://mhealtheconomics.com/wp-content/uploads/2014/05/research2guidance_mHealth_6_segments_business_approaches.jpg

Link to free report:

http://mhealtheconomics.com/mhealth-developer-economics-report/

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

Product Details

Product DetailsProduct Details

%d bloggers like this: